210 related articles for article (PubMed ID: 37435454)
1. Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer.
Treppiedi D; Catalano R; Mangili F; Mantovani G; Peverelli E
Endocr Oncol; 2022 Jan; 2(1):R143-R152. PubMed ID: 37435454
[TBL] [Abstract][Full Text] [Related]
2. A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation.
Mangili F; Treppiedi D; Catalano R; Marra G; Di Muro G; Spada A; Arosio M; Peverelli E; Mantovani G
Front Endocrinol (Lausanne); 2020; 11():611752. PubMed ID: 33664708
[TBL] [Abstract][Full Text] [Related]
3. FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression.
Vitali E; Boemi I; Rosso L; Cambiaghi V; Novellis P; Mantovani G; Spada A; Alloisio M; Veronesi G; Ferrero S; Lania AG
Oncotarget; 2017 Sep; 8(44):77330-77340. PubMed ID: 29100390
[TBL] [Abstract][Full Text] [Related]
4. Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours.
Vitali E; Cambiaghi V; Zerbi A; Carnaghi C; Colombo P; Peverelli E; Spada A; Mantovani G; Lania AG
Endocr Relat Cancer; 2016 Mar; 23(3):181-90. PubMed ID: 26733502
[TBL] [Abstract][Full Text] [Related]
5. The cytoskeleton actin binding protein filamin A impairs both IGF2 mitogenic effects and the efficacy of IGF1R inhibitors in adrenocortical cancer cells.
Catalano R; Giardino E; Treppiedi D; Mangili F; Morelli V; Elli FM; Serban AL; Luconi M; Mannelli M; Spada A; Arosio M; Mantovani G; Peverelli E
Cancer Lett; 2021 Jan; 497():77-88. PubMed ID: 33075426
[TBL] [Abstract][Full Text] [Related]
6. Filamin A: Insights into its Exact Role in Cancers.
Shao QQ; Zhang TP; Zhao WJ; Liu ZW; You L; Zhou L; Guo JC; Zhao YP
Pathol Oncol Res; 2016 Apr; 22(2):245-52. PubMed ID: 26341089
[TBL] [Abstract][Full Text] [Related]
7. FLNA expression modulates pathological markers of pituitary neuroendocrine tumours.
Toledo J; Perez PA; Zanetti M; Díaz-Torga G; Mukdsi JH; Gutierrez S
J Endocrinol; 2024 Jan; 260(1):. PubMed ID: 37855268
[TBL] [Abstract][Full Text] [Related]
8. The dual role of filamin A in cancer: can't live with (too much of) it, can't live without it.
Savoy RM; Ghosh PM
Endocr Relat Cancer; 2013 Dec; 20(6):R341-56. PubMed ID: 24108109
[TBL] [Abstract][Full Text] [Related]
9. Filamin A in somatostatin and dopamine receptor regulation in pituitary and the role of cAMP/PKA dependent phosphorylation.
Peverelli E; Giardino E; Vitali E; Treppiedi D; Lania AG; Mantovani G
Horm Metab Res; 2014 Nov; 46(12):845-53. PubMed ID: 25068602
[TBL] [Abstract][Full Text] [Related]
10. Cytoskeleton actin-binding proteins in clinical behavior of pituitary tumors.
Mantovani G; Treppiedi D; Giardino E; Catalano R; Mangili F; Vercesi P; Arosio M; Spada A; Peverelli E
Endocr Relat Cancer; 2019 Feb; 26(2):R95-R108. PubMed ID: 30589642
[TBL] [Abstract][Full Text] [Related]
11. The function and pathogenic mechanism of filamin A.
Zhou J; Kang X; An H; Lv Y; Liu X
Gene; 2021 Jun; 784():145575. PubMed ID: 33737122
[TBL] [Abstract][Full Text] [Related]
12. Filamin A expression correlates with proliferation and invasive properties of human metastatic melanoma tumors: implications for survival in patients.
Zhang K; Zhu T; Gao D; Zhang Y; Zhao Q; Liu S; Su T; Bernier M; Zhao R
J Cancer Res Clin Oncol; 2014 Nov; 140(11):1913-26. PubMed ID: 24908328
[TBL] [Abstract][Full Text] [Related]
13. The impact of SST2 trafficking and signaling in the treatment of pancreatic neuroendocrine tumors.
Vitali E; Piccini S; Trivellin G; Smiroldo V; Lavezzi E; Zerbi A; Pepe G; Lania AG
Mol Cell Endocrinol; 2021 May; 527():111226. PubMed ID: 33675866
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of filamin A by Cdk1 regulates filamin A localization and daughter cell separation.
Szeto SGY; Williams EC; Rudner AD; Lee JM
Exp Cell Res; 2015 Jan; 330(2):248-266. PubMed ID: 25445790
[TBL] [Abstract][Full Text] [Related]
15. cAMP/PKA-induced filamin A (FLNA) phosphorylation inhibits SST2 signal transduction in GH-secreting pituitary tumor cells.
Peverelli E; Giardino E; Mangili F; Treppiedi D; Catalano R; Ferrante E; Sala E; Locatelli M; Lania AG; Arosio M; Spada A; Mantovani G
Cancer Lett; 2018 Oct; 435():101-109. PubMed ID: 30098401
[TBL] [Abstract][Full Text] [Related]
16. Filamin A (FLNA) plays an essential role in somatostatin receptor 2 (SST2) signaling and stabilization after agonist stimulation in human and rat somatotroph tumor cells.
Peverelli E; Giardino E; Treppiedi D; Vitali E; Cambiaghi V; Locatelli M; Lasio GB; Spada A; Lania AG; Mantovani G
Endocrinology; 2014 Aug; 155(8):2932-41. PubMed ID: 24828612
[TBL] [Abstract][Full Text] [Related]
17. Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells.
Treppiedi D; Di Muro G; Mangili F; Catalano R; Giardino E; Barbieri AM; Locatelli M; Arosio M; Spada A; Peverelli E; Mantovani G
Mol Cell Endocrinol; 2021 Mar; 524():111159. PubMed ID: 33428965
[TBL] [Abstract][Full Text] [Related]
18. A novel pathway activated by somatostatin receptor type 2 (SST2): Inhibition of pituitary tumor cell migration and invasion through cytoskeleton protein recruitment.
Peverelli E; Giardino E; Treppiedi D; Catalano R; Mangili F; Locatelli M; Lania AG; Arosio M; Spada A; Mantovani G
Int J Cancer; 2018 May; 142(9):1842-1852. PubMed ID: 29226331
[TBL] [Abstract][Full Text] [Related]
19. Valvular dystrophy associated filamin A mutations reveal a new role of its first repeats in small-GTPase regulation.
Duval D; Lardeux A; Le Tourneau T; Norris RA; Markwald RR; Sauzeau V; Probst V; Le Marec H; Levine R; Schott JJ; Merot J
Biochim Biophys Acta; 2014 Feb; 1843(2):234-44. PubMed ID: 24200678
[TBL] [Abstract][Full Text] [Related]
20. Dopamine and Somatostatin Analogues Resistance of Pituitary Tumors: Focus on Cytoskeleton Involvement.
Peverelli E; Treppiedi D; Giardino E; Vitali E; Lania AG; Mantovani G
Front Endocrinol (Lausanne); 2015; 6():187. PubMed ID: 26733942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
